Romina Quercia

881 total citations
16 papers, 491 citations indexed

About

Romina Quercia is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Romina Quercia has authored 16 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Romina Quercia's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Romina Quercia is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Romina Quercia collaborates with scholars based in United Kingdom, United States and France. Romina Quercia's co-authors include Elisabeth Dam, François Clavel, Jeremy Roberts, Carlos Zala, Justin Koteff, Danielle Perez-Bercoff, Allan J. Hance, Odile Launay, Hans‐Georg Kräusslich and Diane Descamps and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and PLoS Pathogens.

In The Last Decade

Romina Quercia

15 papers receiving 479 citations

Peers

Romina Quercia
Homayoon Khanlou United States
Céline Colin France
Miguel Goicoechea United States
Juan Tiraboschi Spain
Lorant Leopold United States
Christopher Stone United States
Frank-D. Goebel Germany
Saadia Mokhtari France
Trevor R. Scott United States
Rima Acosta United States
Homayoon Khanlou United States
Romina Quercia
Citations per year, relative to Romina Quercia Romina Quercia (= 1×) peers Homayoon Khanlou

Countries citing papers authored by Romina Quercia

Since Specialization
Citations

This map shows the geographic impact of Romina Quercia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romina Quercia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romina Quercia more than expected).

Fields of papers citing papers by Romina Quercia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romina Quercia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romina Quercia. The network helps show where Romina Quercia may publish in the future.

Co-authorship network of co-authors of Romina Quercia

This figure shows the co-authorship network connecting the top 25 collaborators of Romina Quercia. A scholar is included among the top collaborators of Romina Quercia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romina Quercia. Romina Quercia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Quercia, Romina, et al.. (2024). Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review. Infectious Diseases and Therapy. 13(5). 1005–1017. 4 indexed citations
2.
Hendrick, Victoria, et al.. (2024). Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir. Infectious Diseases and Therapy. 13(12). 2545–2561. 3 indexed citations
3.
Rawlings, M. Keith, Romina Quercia, Richard Grove, et al.. (2022). Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups. Open Forum Infectious Diseases. 9(8). ofac304–ofac304. 3 indexed citations
4.
5.
Boffito, Marta, Laura Waters, Pedro Cahn, et al.. (2019). Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection. AIDS Research and Human Retroviruses. 36(1). 13–18. 28 indexed citations
6.
Vannappagari, Vani, Leigh Ragone, Cassidy Henegar, et al.. (2018). Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. 24(6). 393–404. 13 indexed citations
7.
Quercia, Romina, Carlo Federico Perno, Justin Koteff, et al.. (2018). Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 78(2). 125–135. 65 indexed citations
8.
Quercia, Romina. (2016). Dolutegravir based regimens (DBRS) viral load decay at week 4 could predict sustained viral suppression at week 96. Journal of the International AIDS Society. 19(2).
9.
Winston, Alan, Naomi Givens, Vani Vannappagari, et al.. (2016). Psychiatric Symptoms in Patients Receiving Dolutegravir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(4). 423–431. 75 indexed citations
10.
11.
Tebas, Pablo, Martin Fisher, Brian Gazzard, et al.. (2013). Efficacy of switching to rilpivirine/emtricitabine/tenofovir DF from boosted PI in HIV-1 virologically suppressed patients with or without the K103N. Journal of the International AIDS Society. 16(Suppl 1). 2 indexed citations
12.
Dam, Elisabeth, Romina Quercia, Bärbel Glass, et al.. (2009). Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss. PLoS Pathogens. 5(3). e1000345–e1000345. 112 indexed citations
13.
Quercia, Romina, Elisabeth Dam, Danielle Perez-Bercoff, & François Clavel. (2009). Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes. Journal of Virology. 83(19). 10245–10249. 49 indexed citations
14.
Pialoux, Gilles, Romina Quercia, Hanne Gahéry, et al.. (2008). Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study. Clinical and Vaccine Immunology. 15(3). 562–568. 21 indexed citations
15.
Quercia, Romina, et al.. (2005). Salvage Therapy with Ritonavir-Boosted Amprenavir/Fosamprenavir: Virological and Immunological Response in Two Years Follow-up. HIV Clinical Trials. 6(2). 73–80. 9 indexed citations
16.
Wood, Evan, Robert S. Hogg, Benita Yip, et al.. (2003). Higher Baseline Levels of Plasma Human Immunodeficiency Virus Type 1 RNA Are Associated with Increased Mortality after Initiation of Triple‐Drug Antiretroviral Therapy. The Journal of Infectious Diseases. 188(10). 1421–1425. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Homayoon Khanlou Breakdown of academic impact, for papers by Céline Colin Breakdown of academic impact, for papers by Miguel Goicoechea Breakdown of academic impact, for papers by Juan Tiraboschi Breakdown of academic impact, for papers by Lorant Leopold Breakdown of academic impact, for papers by Christopher Stone Breakdown of academic impact, for papers by Frank-D. Goebel Breakdown of academic impact, for papers by Saadia Mokhtari Breakdown of academic impact, for papers by Trevor R. Scott Breakdown of academic impact, for papers by Rima Acosta
Rankless by CCL
2026